U.S. Markets close in 3 hrs 35 mins

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
84.40+1.76 (+2.13%)
As of 12:25PM EDT. Market open.
People also watch
Full screen
Previous Close82.64
Bid84.53 x 400
Ask84.55 x 200
Day's Range82.91 - 84.76
52 Week Range64.18 - 86.72
Avg. Volume3,789,485
Market Cap88.78B
PE Ratio (TTM)40.81
EPS (TTM)2.07
Earnings DateJul 25, 2017
Dividend & Yield2.08 (2.51%)
Ex-Dividend Date2017-05-11
1y Target Est89.00
Trade prices are not sourced from all markets
  • The Wall Street Journal4 minutes ago

    Health-Care Stocks Get a Boost From Senate Bill Rollout

    Health care stocks got a lift Thursday after Senate Republicans rolled out their proposed bill to repeal Obamacare.

  • Eli Lilly and Company Unveils Expanded Biotechnology Center in San Diego
    PR Newswireyesterday

    Eli Lilly and Company Unveils Expanded Biotechnology Center in San Diego

    Lilly's new space will help foster and accelerate the discovery of medicines within the company's core therapeutic areas of immunology, diabetes, oncology and neurodegeneration, as well as the emerging area of pain. "This year we announced a commitment to invest $850 million in our U.S. operations based on our potential for growth and the company's long-standing investment in the U.S. market," said David A. Ricks, Lilly's chairman, president and chief executive officer.

  • Market Realist2 days ago

    Analyzing Eli Lilly’s Collaboration with KeyBioscience AG

    On June 8, 2017, Eli Lilly (LLY) announced a strategic collaboration with KeyBioscience AG to focus on the development of dual amylin calcitonin receptor agonists (or DACRAs).